Sweden-based Pharmalink nets $15 mln in Series C financing
Pharmalink AB said Friday that it has raised SEK96 million ($15 million) in Series C financing. Investinor and return backer Industrifonden led the round. Based in Stockholm, Sweden, Pharmalink is a specialty pharma company that develops niche products.
4 October 2013•5 mins read
